Center for Infection Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, 14186 Stockholm, Sweden.
Clin Immunol. 2010 Apr;135(1):12-25. doi: 10.1016/j.clim.2009.12.005. Epub 2010 Jan 25.
Innate immune responses are critical in the defense against viral infections. NK cells, myeloid and plasmacytoid dendritic cells, and invariant CD1d-restricted NKT cells mediate both effector and regulatory functions in this early immune response. In chronic uncontrolled viral infections such as HCV and HIV-1, these essential immune functions are compromised and can become a double edged sword contributing to the immunopathogenesis of viral disease. In particular, recent findings indicate that innate immune responses play a central role in the chronic immune activation which is a primary driver of HIV-1 disease progression. HCV/HIV-1 co-infection is affecting millions of people and is associated with faster viral disease progression. Here, we review the role of innate immunity and chronic immune activation in HCV and HIV-1 infection, and discuss how mechanisms of innate immunity may influence protection as well as immunopathogenesis in the HCV/HIV-1 co-infected human host.
先天免疫反应在抵抗病毒感染中至关重要。NK 细胞、髓样和浆细胞样树突状细胞以及不变的 CD1d 限制性 NKT 细胞在这种早期免疫反应中发挥效应和调节功能。在慢性未控制的病毒感染如 HCV 和 HIV-1 中,这些基本的免疫功能受到损害,可能成为双刃剑,导致病毒疾病的免疫发病机制。特别是,最近的研究结果表明,先天免疫反应在慢性免疫激活中起核心作用,慢性免疫激活是 HIV-1 疾病进展的主要驱动因素。HCV/HIV-1 合并感染影响着数百万人,并且与更快的病毒疾病进展相关。在这里,我们综述了先天免疫和慢性免疫激活在 HCV 和 HIV-1 感染中的作用,并讨论了先天免疫机制如何影响 HCV/HIV-1 合并感染宿主的保护和免疫发病机制。